The administration of galectin-9 to mice with HSV-induced Behçet’s disease inhibits pro-inflammatory cytokine production, attenuates inflammation, and reduces disease severity; however, galectin-9 administration also increases the number of Tregs [71]. The gene discussed is LGALS9; the disease is Behcet disease.